XTX Topco »

Apimeds Pharmaceuticals Us I shares owned by XTX Topco

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by XTX Topco

Quarter filed Position value Share count Share price at filing
2025-09-30 $33k 19k 1.78

More positions owned by XTX Topco

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Johnson & Johnson (JNJ)
Cme (CME)
Thermo Fisher Scientific (TMO)
Cisco Systems (CSCO)
Bristol Myers Squibb (BMY)
Enbridge (ENB)
American Tower Reit (AMT)
Us Bancorp Del Com New (USB)
American Intl Group Com New (AIG)
TJX Companies (TJX)
Southern Company (SO)
Stellantis SHS (STLA)
Ares Management Corporation Cl A Com Stk (ARES)

View all positions for XTX Topco

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Renaissance Technologies
XTX Topco
Hrt Financial
Jpmorgan Chase & Co

View all funds holding Apimeds Pharmaceuticals Us I